FBC testing

Why FBC Testing

Regular FBC testing for clozapine patients is a Medicines and Healthcare products  Regulatory Agency (MHRA) requirement for all patients receiving clozapine treatment. We can provide:

• Same day turnaround from day of receipt to minimise the risk of unplanned treatment breaks or to enable rapid intervention if Adverse Drug Reactions such as agranulocytosis or neutropenia have occurred
• Blood Sampling kits which include safety needles as standard, together with patient labels and postage
• Results reported via Leyden Delta’s™ ZTAS™ Patient Monitoring website

Magna Laboratories™ FBC testing has been accredited by UKAS (ISO 15189:2012)